Carsten Brunn - 03 Jan 2022 Form 4 Insider Report for SELECTA BIOSCIENCES INC (RNAC)

Role
President and CEO, Director
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Carsten Brunn
Issuer symbol
RNAC
Transactions as of
03 Jan 2022
Net transactions value
$0
Form type
4
Filing time
05 Jan 2022, 15:32:03 UTC
Previous filing
14 Dec 2021
Next filing
07 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SELB Common Stock Award $0 +226,300 +74% $0.000000 531,555 03 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SELB Employee Stock Option (right to buy) Award $0 +1,056,100 $0.000000 1,056,100 03 Jan 2022 Common Stock 1,056,100 $3.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 3, 2023. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 3, 2026.
F2 This option vests as to 25% on January 3, 2023. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.